MCL1 and osteosarcoma: Confirming expression of MCL1 in human osteosarcoma metastases and spontaneous canine osteosarcoma metastases argues for further testing of MCL1 inhibitors in canine cell lines and eventually canine clinical trials as a vetting process prior to human clinical trials.